My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

Exscientia Plc - American Depositary Shares (NQ:EXAI)

4.840 UNCHANGED

Last Price Updated: 4:00 PM EST, Nov 19, 2024 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Exscientia Plc - American Depositary Shares

< Previous 1 2 3 4 5 Next >

EXAI Stock Earnings: Exscientia Beats EPS, Misses Revenue for Q1 2024 ↗

May 21, 2024

EXAI stock results show that Exscientia beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024.

Via InvestorPlace

A $50B AI Drug Discovery Revolution Has Begun - Here Are 6 Stocks To Consider Investing In ↗

May 20, 2024

The drug development process is very expensive and time-consuming which creates a huge shortage in drug candidates and programs but the advent of AI can significantly shorten and cheapen this process...

Via Talk Markets

Topics Artificial Intelligence

All 7 Artificial Intelligence (AI) Categories Reversed Direction This Week ↗

May 18, 2024

All 7 of the AI categories we track were up 2.9%, on average, this week.

Via Talk Markets

Topics Artificial Intelligence

7 Pharma Stocks Harnessing AI Brainpower for Big Breakthroughs ↗

May 16, 2024

AI continues to impact pharma stocks to buy in a major way, with these shares particularly well positioned as things heat up.

Via InvestorPlace

Topics Artificial Intelligence

Largest Clinical-Stage BioTech Drug Stocks Declined 3% Last Week ↗

May 13, 2024

Via Talk Markets

Exscientia Earnings Preview ↗

March 20, 2024

Via Benzinga

Clinical-Stage BioTech Drug Stocks Portfolio Jumped 7% In First Week Of May ↗

May 05, 2024

We look at the performance of 10 clinical-stage AI-powered and psychedelic compound-based small cap drug discovery companies during the first week of May and YTD.

Via Talk Markets

Tesla, Deciphera Pharmaceuticals, Heartland Financial And Other Big Stocks Moving Higher On Monday ↗

April 29, 2024

Via Benzinga

The 10 Stocks In The Clinical-Stage BioTech Drug Stocks Index Are Down 4% YTD ↗

April 15, 2024

The pharmaceutical industry is embracing AI to streamline drug discovery and researching the use of psychedelic compound-based ingredients for the treatment of, as yet, untreatable diseases.

Via Talk Markets

Topics Artificial Intelligence

Six Of Seven AI Stock Categories Increased This Week ↗

March 23, 2024

All but one of the 7 artificial intelligence stock categories that I analyze weekly increased in value this week. But two categories are still down MTD, suggesting that the surge in the artificial...

Via Talk Markets

Topics Artificial Intelligence

Why Ulta Beauty Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

April 03, 2024

Shares of Ulta Beauty, Inc. (NASDAQ: ULTA) fell sharply during Wednesday’s session amid the company's presentation at the J.P. Morgan Retail Roundup investor conference where the company reportedly...

Via Benzinga

EXAI Stock Earnings: Exscientia Misses EPS, Misses Revenue for Q4 2023 ↗

March 21, 2024

EXAI stock results show that Exscientia missed analyst estimates for earnings per share and missed on revenue for the fourth quarter of 2023.

Via InvestorPlace

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

March 21, 2024

Via Benzinga

Earnings Scheduled For March 21, 2024 ↗

March 21, 2024

Companies Reporting Before The Bell • Creative Realities (NASDAQ:CREX) is expected to report quarterly earnings at $0.02 per share on revenue of $16.47 million.

Via Benzinga

The Top 3 Healthcare Stocks to Buy on Weakness in 2024 ↗

March 04, 2024

Many healthcare stocks have extremely bright outlooks and very low valuations. Here are three top healthcare stocks to buy.

Via InvestorPlace

AI-Powered Drug Discovery Stocks Index Up 9% In February; Remains Down 8% YTD ↗

March 04, 2024

Grand View Research says the global

Via Talk Markets

AI-Powered Drug Discovery Stocks Index Up 18% Last Week, Led By BioXcel Therapeutics ↗

February 19, 2024

The AI-powered drug discovery market is projected to grow at a 30% CAGR between now and 2030, with annual sales in excess of $50 billion anticipated. An AI drug discovery revolution is underway.

Via Talk Markets

Topics Artificial Intelligence

AI Drug Hunter Firm Exscientia Fires Its CEO Over 'Inappropriate' Relationships with Two Employees ↗

February 13, 2024

Exscientia terminates CEO Andrew Hopkins over inappropriate relationships with employees. Interim CEO appointed.

Via Benzinga

Topics Artificial Intelligence

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

February 12, 2024

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday ↗

February 12, 2024

We're starting the trading week with a breakdown of the biggest pre-market stock movers worth reading about for Monday morning!

Via InvestorPlace

Why IPG Photonics Shares Are Trading Lower By Around 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

February 13, 2024

Shares of IPG Photonics Corporation (NASDAQ: IPGP) fell sharply during Tuesday’s session after the company reported mixed fourth-quarter financial results and issued soft first-quarter guidance.

Via Benzinga

Why WD-40 Shares Are Trading Higher By Over 17%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

January 10, 2024

Shares of WD-40 Company (NASDAQ: WDFC) rose sharply during Wednesday’s session after the company reported better-than-expected first-quarter results.

Via Benzinga

Why Applied Therapeutics Shares Are Trading Lower By Over 35%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

January 05, 2024

Shares of Applied Therapeutics, Inc.

Via Benzinga

M&A Watch: 3 Drug Maker Stocks That Could Be Acquired in 2024 ↗

January 02, 2024

Lower interest rates and the low valuation of many biotech stocks are likely to result in many drug maker stocks being acquired in 2024.

Via InvestorPlace

Top Picks 2024: Exscientia Plc ↗

December 31, 2023

Founded in 2012 and based in Oxford, England, Exscientia Plc is using Artificial Intelligence to develop new medicines and is attracting high-quality partners. It has a rapidly growing pipeline of more...

Via Talk Markets

Topics Artificial Intelligence

AI-Focused Drug Discovery Stocks Index Up 26% In December ↗

December 29, 2023

With the promise of lower costs and shorter development timelines, AI-enabled drug discovery holds massive potential to increase the accessibility of drugs and to treat presently incurable conditions.

Via Talk Markets

AI-Focused Drug Discovery Stocks Index Up 10.6% Last Week ↗

December 17, 2023

A new study concludes that the AI method of drug discovery is up to 250 times more efficient than the traditional method.

Via Talk Markets

Topics Artificial Intelligence

The 10 Stocks Using AI To Develop New Drugs Were Up 4%, On Average, Last Week ↗

December 11, 2023

If, as Morgan Stanley postulates, a $50 billion AI drug discovery revolution is underway, here are 10 publicly-traded micro- and small-cap clinical stage pharma companies that are embracing AI to...

Via Talk Markets

Topics Artificial Intelligence

Looking for the Next Big Thing? Add This AI Biotech to Your Watch List Right Now ↗

December 07, 2023

Exscientia has the potential to be a star collaborator and a profitable drug developer, too.

Via The Motley Fool

Topics Artificial Intelligence

Micro/Small Cap Companies Using AI In Drug Discovery Up 35% In November ↗

December 06, 2023

The AI method is up to 250 times more efficient than the traditional method of drug discovery. reducing timelines for drug discovery, increasing accuracy of efficacy and safety predictions.

Via Talk Markets

Topics Artificial Intelligence

< Previous 1 2 3 4 5 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.